The goal of this clinical trial is to investigate the effect of menstrual cycle phases on postprandial triglyceride concentrations in healthy young female adults. The main question it aims to answer is: do postprandial triglyceride concentrations differ between the follicular and luteal phases of the menstrual cycle? Participants will: visit the laboratory for a preliminary screening session to assess eligibility, and undergo two experimental sessions consisting of six hours of seated rest following the consumption of a high-fat meal (one session conducted in the early follicular phase, and one session conducted in the mid-luteal phase of the menstrual cycle).
Age range
18 Years – 30 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Change from baseline in plasma total triglyceride concentrations
Timeframe: 6 hours
Change from baseline in plasma buoyant triglyceride concentrations
Timeframe: 6 hours
Change from baseline in plasma denser triglyceride concentrations
Timeframe: 6 hours
Change from baseline in plasma non-esterified fatty acid concentrations
Timeframe: 6 hours
Change from baseline in plasma insulin concentrations
Timeframe: 6 hours
Change from baseline in plasma glucose concentrations
Timeframe: 6 hours
Change from baseline in plasma β-hydroxybutyrate concentrations
Timeframe: 6 hours